Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong, China
Lists
Only you see this
Abstract
Long-term TDF-containing ART has high anti-HBV efficacy including relatively high overall HBsAg seroclearance in HBV/HIV co-infected patients. Lower baseline HBsAg levels, HBV genotype B, and elevated ALT levels during the first six months of ART are potential predictors of HBsAg seroclearance.
BibTeX
@inproceedings{he2023incidence,
author = {Yaozu He and Weiyin Lin and Hong Li and Fei Gu and Huolin Zhong and Yun Lan and Yonghong Li and Pengle Guo and Fengyu Hu and Weiping Cai and Xiaoping Tang and Linghua Li},
title = {{Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong, China}},
booktitle = {Chinese},
year = {2023},
doi = {10.1097/cm9.0000000000002886},
}Loading related content...